These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18580953)

  • 1. Molecular insights into the morphology of myeloproliferative neoplasms using an in situ PCR assay specific for the JAK2 mutation V617F.
    Gattenlohner S; Serfling E; Einsele H; Müller-Hermelink HK
    Leukemia; 2009 Jan; 23(1):196-9. PubMed ID: 18580953
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid real-time PCR assay for detection of MPL W515L mutation in patients with chronic myeloproliferative disorders.
    Ghaderi M; Strömberg O; Porwit A
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 2):122-6. PubMed ID: 19016916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders.
    Rumi E; Passamonti F; Pietra D; Della Porta MG; Arcaini L; Boggi S; Elena C; Boveri E; Pascutto C; Lazzarino M; Cazzola M
    Cancer; 2006 Nov; 107(9):2206-11. PubMed ID: 16998940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The investigation of JAK2 V617F point mutation in myeloproliferative disorders by allele-specific polymerase chain reaction in combination with sequence analysis].
    Zhang SJ; Li WD; Song JH; Xu W; Qiu HX; Li JY
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(30):2109-12. PubMed ID: 17988529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
    Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of acquired Janus kinase 2 V617F mutation in myeloproliferative disorders by fluorescence melting curve analysis.
    Reading NS; Lim MS; Elenitoba-Johnson KS
    Mol Diagn Ther; 2006; 10(5):311-7. PubMed ID: 17022694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JAK2 V617F mutation detection: laboratory comparison of two kits using RFLP and qPCR.
    Shammaa D; Bazarbachi A; Halas H; Greige L; Mahfouz R
    Genet Test Mol Biomarkers; 2010 Feb; 14(1):13-5. PubMed ID: 19877761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accurate quantitation of JAK2 V617F allele burden by array-based digital PCR.
    Kinz E; Leiherer A; Lang AH; Drexel H; Muendlein A
    Int J Lab Hematol; 2015 Apr; 37(2):217-24. PubMed ID: 24963593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of the JAK2 V617F missense mutation by high resolution melting analysis and its validation.
    Er TK; Lin SF; Chang JG; Hsieh LL; Lin SK; Wang LH; Lin CW; Chang CS; Liu TC
    Clin Chim Acta; 2009 Oct; 408(1-2):39-44. PubMed ID: 19595684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow mesenchymal stromal cells of patients with myeloproliferative disorders do not carry the JAK2-V617F mutation.
    Mercier F; Monczak Y; François M; Prchal J; Galipeau J
    Exp Hematol; 2009 Mar; 37(3):416-20. PubMed ID: 19135773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple, rapid, and sensitive method for the detection of the JAK2 V617F mutation.
    Tan AY; Westerman DA; Dobrovic A
    Am J Clin Pathol; 2007 Jun; 127(6):977-81. PubMed ID: 17509995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BsaXI/RFLP analysis of initial or selectively reamplified PCR product is unreliable in detecting the V617F mutation in JAK2.
    Shepard GC; Lawson HL; Hawkins GA; Owen J
    Int J Lab Hematol; 2011 Jun; 33(3):267-71. PubMed ID: 21118387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quantitative assay for JAK2(V617F) mutation in myeloproliferative disorders by ARMS-PCR and capillary electrophoresis.
    Vannucchi AM; Pancrazzi A; Bogani C; Antonioli E; Guglielmelli P
    Leukemia; 2006 Jun; 20(6):1055-60. PubMed ID: 16572198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JAK2 V617F: implications for thrombosis in myeloproliferative diseases.
    Hexner EO
    Curr Opin Hematol; 2007 Sep; 14(5):450-4. PubMed ID: 17934351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations of JAK2-V617F mutation with clinical and laboratory findings in patients with myeloproliferative disorders.
    Speletas M; Katodritou E; Daiou C; Mandala E; Papadakis E; Kioumi A; Ritis K; Korantzis I
    Leuk Res; 2007 Aug; 31(8):1053-62. PubMed ID: 17045648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification refractory mutation system, a highly sensitive and simple polymerase chain reaction assay, for the detection of JAK2 V617F mutation in chronic myeloproliferative disorders.
    Chen Q; Lu P; Jones AV; Cross NC; Silver RT; Wang YL
    J Mol Diagn; 2007 Apr; 9(2):272-6. PubMed ID: 17384221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical performance of JAK2 V617F mutation detection assays in a molecular diagnostics laboratory: evaluation of screening and quantitation methods.
    Cankovic M; Whiteley L; Hawley RC; Zarbo RJ; Chitale D
    Am J Clin Pathol; 2009 Nov; 132(5):713-21. PubMed ID: 19846812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a quantitative real-time polymerase chain reaction assay for the detection of the JAK2 V617F mutation.
    Wolstencroft EC; Hanlon K; Harries LW; Standen GR; Sternberg A; Ellard S
    J Mol Diagn; 2007 Feb; 9(1):42-6. PubMed ID: 17251334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JAK2-V617F mutation in Moroccan patients with myeloproliferative disorders: contribution, diagnosis and therapeutic prospects.
    Benmoussa A; Dehbi H; Fehri S; Quessar A; Nadifi S
    Pathol Biol (Paris); 2011 Aug; 59(4):e89-92. PubMed ID: 19939582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the JAK2(V617F) mutation detectable in healthy volunteers?
    Martinaud C; Brisou P; Mozziconacci MJ
    Am J Hematol; 2010 Apr; 85(4):287-8. PubMed ID: 20162546
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.